North America dominates the Urological Operating Tables market with a 35% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust reimbursement policies. Europe follows with 30%, supported by aging demographics, stringent regulatory frameworks ensuring quality standards, and strong investments in urological care. The Asia Pacific region, at 20%, is the fastest-growing market, fueled by rising healthcare investments, increasing prevalence of urological disorders, and expanding access to surgical facilities. Latin America (10%) and the Middle East & Africa (5%) face slower growth due to fragmented healthcare ecosystems and limited funding, though demand is rising with urbanization and technology transfers.